Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T04:50:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A government funding status notice was added and the page revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T03:31:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page adds a glossary display and updates QC-related metadata, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:40:30.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor version bump and does not alter study content or critical functionality.
    Difference
    0.1%
    Check dated 2026-01-14T01:58:54.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Update added in Study Record: last known status and updater (Wilson Miller, Jewish General Hospital) with date 2021-02 and verification status.
    Difference
    0.4%
    Check dated 2026-01-06T22:51:15.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now includes a Locations section with a Quebec site; the Quebec Locations entry and the HHS Vulnerability Disclosure link were removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:39:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.